Rezomast®
Treatment and prevention of mastitis cattle
Cattle mastitis – is a disease manifested in dairy cattle, inflammation of the mammary glands
Rezomast® solves the problem:
The global incidence of mastitis is more than 30% of the total dairy herd. The growing prevalence of cattle mastitis worldwide has a direct impact on the growth of the entire market. The economic losses associated with mastitis problems can range from $200 to $400 per case. Prohibition of the use of antibiotics in the prevention of mastitis.
Market volume $1.7 billion
TAM in 2020 CAGR 5,2%
Advantages of Rezomast®
- No waiting period after use
- Does not require a high concentration of DV in the focus of infection
- Allows you to quickly and evenly distribute DV
- Safe. Fully excreted during milking
- Does not affect the properties of milk
- All DV are approved for use in veterinary medicine
- High degree and speed (2.8X) of somatics level normalization
- Does not require milk rejection
- Used in both lactation and dry periods
- Long-lasting effect of the drug (3.4X)
Innovative technology solution
Using synthetic analogues of microbial regulatory molecules as active substances (DV), it allows you to suppress the pathogenicity and proliferative activity of mastitis pathogens in cows, without resorting to the principle of direct destruction of bacteria.
Stimulates the immune response and reaction
The chemical formula also includes substances that modulate the immune response and reaction of connective tissue cells to the introduction of pathogen bacteria, which allows to block the pro-inflammatory functions of neutrophils, increase local immunity in the center of infection, which leads to rapid breast sanitization and a combination of inflammatory response.
Status for Rezomast® drugs
Production
Results of Rezomast® production tests
The tested veterinary drug Rezomast is a safe treatment for cows with subclinical and clinical mastitis.
The specificity of the mechanism of action of the drug and the features of its composition provide a stable therapeutic efficacy during the period of its use and a delayed effect after discontinuation of the drug (while maintaining positive dynamics towards recovery), consisting in stopping inflammatory changes in the mammary gland and reducing the risk of recurrence of the disease.
Rezomast does not contain antibiotics, does not have waiting periods for milk, has a stable and long-lasting therapeutic efficacy, helps to stop inflammatory changes in the breast tissue and reduces the risk of recurrence of the disease.
The results of the study of the use of Rezomast in industrial conditions give grounds for its use as an effective tool for the treatment of subclinical and clinical mastitis.
Why Stemtrix is a revolutionary alternative to antibiotics?
Stemtrix preparations do not kill, but serve as mediators of the transition of their pathogens from an active state to a vegetative one. Stemtrix is a radical reduction in the use of antibacterial drugs and antibiotics. The drugs are intended for the prevention and treatment of intestinal and other inflammatory infections of a bacterial nature.
Component of feeds
The active substances of the drug are natural components of the diets of farm animals and birds used in medicine and food industry
No resistance
The active ingredients of the drug are natural regulators of metabolic processes in the bacterial cell, as a result the bacterial cell has no mechanisms of resistance
Without destruction
The drugs will suppress virulence, pathogenicity of pathogenic bacteria, without resorting to the principle of direct destruction of the bacterium
Immune system
The preparations also include substances that modulate the immune response to the introduction of pathogenic bacteria into the body